Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Early research (Phase 1)Looking for participantsNCT06500819What this trial is testingAutologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid TumorsWho this might be right forNeuroblastomaSarcomaOsteosarcoma Stanford University 41
Testing effectiveness (Phase 2)UnknownNCT03651375What this trial is testingHypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallWho this might be right forSarcomaFibrosarcomaLeiomyosarcoma+14 more Maria Sklodowska-Curie National Research Institute of Oncology 46
Testing effectiveness (Phase 2)Study completedNCT02428192What this trial is testingNivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine LeiomyosarcomaWho this might be right forMetastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT04076579What this trial is testingTrabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic SarcomaWho this might be right forSarcomaSarcoma Metastatic University of Michigan Rogel Cancer Center 29
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT01141491What this trial is testingTrivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease FreeWho this might be right forSarcoma MabVax Therapeutics, Inc. 136
Early research (Phase 1)Study completedNCT02644460What this trial is testingAbemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsWho this might be right forDiffuse Intrinsic Pontine GliomaBrain Tumor, RecurrentSolid Tumor, Recurrent+5 more Emory University 53
Testing effectiveness (Phase 2)Study completedNCT00400569What this trial is testingPhase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaWho this might be right forLiposarcomaLeiomyosarcomaFibrosarcoma+1 more H. Lee Moffitt Cancer Center and Research Institute 48
Large-scale testing (Phase 3)Study completedNCT00002764What this trial is testingSurgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerMetastatic Cancer+3 more European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Looking for participantsNCT04370587What this trial is testingA Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorMelanomaHNSCC+3 more ImmVira Pharma Co. Ltd 30
Testing effectiveness (Phase 2)Study completedNCT00831844What this trial is testingCixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forAdult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)UnknownNCT05193214What this trial is testingA Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic SarcomaWho this might be right forSarcoma, Soft Tissue Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 30
Not applicableWithdrawnNCT03868475What this trial is testingComparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast LesionsWho this might be right forBreast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)Study completedNCT00023998What this trial is testingChemotherapy With or Without Trastuzumab in Treating Patients With Metastatic OsteosarcomaWho this might be right forMetastatic Osteosarcoma National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04458922What this trial is testingTesting Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced ChondrosarcomaWho this might be right forCentral Chondrosarcoma, Grade 2Central Chondrosarcoma, Grade 3Dedifferentiated Chondrosarcoma+3 more National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00098579What this trial is testingDoxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryWho this might be right forGastrointestinal Stromal TumorRecurrent Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT02452554What this trial is testingLorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial SarcomaWho this might be right forPleuropulmonary BlastomaRecurrent Malignant Peripheral Nerve Sheath TumorRecurrent Neuroblastoma+3 more Children's Oncology Group 62
Early research (Phase 1)Active Not RecruitingNCT04521686What this trial is testingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsWho this might be right forCholangiocarcinomaChondrosarcomaGlioma+1 more Eli Lilly and Company 200
Testing effectiveness (Phase 2)Study completedNCT00659360What this trial is testingAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaWho this might be right forAdult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more National Cancer Institute (NCI) 17